Treatment with eptinezumab demonstrated meaningful improvements in patients with chronic migraine experiencing a high frequency of severe migraines

Authors
Category Primary study
ConferenceHeadache
Year 2019
This article has no abstract
Epistemonikos ID: be192b8896eefeae1c640a2b25b05eab41cef488
First added on: Apr 30, 2026